Showing results (91-100 of 160) with videos related to

Sort By:
Pageof 16
Journal of Neurotrauma|December 26, 2013
Functional status after blast-plus-impact complex concussive traumatic brain injury in evacuated United States military personnelChristine L MacDonald, Ann M Johnson, Elliot C Nelson, et al.
AIDS Patient Care and Stds|February 17, 2010
Patient-reported outcomes in virologically suppressed, HIV-1-Infected subjects after switching to a simplified, single-tablet regimen of efavirenz, emtricitabine, and tenofovir DFSally L Hodder, Karam Mounzer, Edwin Dejesus, et al.
Journal of Medical Virology|May 28, 2014
Evaluation of HBV DNA decay kinetics in patients containing both rtM204V/I mutant and wild-type HBV subpopulations during tenofovir DF (TDF) monotherapy or combination therapy with emtricitabine (FTC)/TDFYang Liu, Scott Fung, Edward J Gane, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 15, 2014
No resistance to tenofovir disoproxil fumarate through 96 weeks of treatment in patients with lamivudine-resistant chronic hepatitis BAmoreena C Corsa, Yang Liu, John F Flaherty, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|November 25, 2024
Targeted Temperature Management After Pediatric Cardiac Arrest: A Quality Improvement Program With Multidisciplinary Implementation in the PICUMason P McMullin, Noelle B Cadotte, Erin M Fuchs, et al.
Journal of Palliative Medicine|October 25, 2023
Grieving Children' Death in an Intensive Care Unit: Implementation of a Standardized ProcessClaudia Delgado-Corcoran, Sarah E Wawrzynski, Kelly Mansfield, et al.
The Journal of Trauma|April 11, 2008
Complications after fasciotomy revision and delayed compartment release in combat patientsAmber E Ritenour, Warren C Dorlac, Raymond Fang, et al.
BMC Nephrology|April 2, 2025
Chronic hepatitis B virus infection increases the risk of kidney disease while antiviral therapy for hepatitis B virus can decrease kidney disease riskKaori L Ito, Yuqing Zhang, Biao Li, et al.
Journal of Viral Hepatitis|September 24, 2016
No detectable resistance to tenofovir disoproxil fumarate in HBeAg+ and HBeAg- patients with chronic hepatitis B after 8 years of treatmentY Liu, A C Corsa, M Buti, et al.
Journal of Viral Hepatitis|January 2, 2024
Real-world safety and effectiveness of tenofovir alafenamide for 144 weeks in Japanese patients with chronic hepatitis BShuhei Hige, Kouji Aoki, Daisuke Nakamoto, et al.
Pageof 16